Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Ipca Laboratories Ltd

+ Add to Watchlist

IPCA:IN

665.40 INR 8.55 1.30%

As of 06:06:05 ET on 03/02/2015.

Snapshot for Ipca Laboratories Ltd (IPCA)

Open: 659.00 Day's Range: 658.00 - 674.70 Volume: 129,788
Previous Close: 656.85 52wk Range: 591.25 - 906.00 1-Yr Rtn: -24.75%

Stock Chart for IPCA

No chart data available.
  • IPCA:IN 665.40
  • 1D
  • 1M
  • 1Y
656.85
Interactive IPCA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IPCA

Current P/E Ratio (ttm) 17.5475
Estimated P/E(03/2015) 23.5907
Relative P/E vs. SENSEX 0.8615
Earnings Per Share (INR) (ttm) 37.9200
Est. EPS (INR) (03/2015) 28.2060
Est. PEG Ratio 1.0039
Market Cap (M INR) 83,953.59
Shares Outstanding (M) 126.17
30 Day Average Volume 333,389
Price/Book (mrq) 4.2851
Price/Sale (ttm) 2.6008
Dividend Indicated Gross Yield 0.38%
Cash Dividend (INR) 2.5000
Dividend Ex-Date 07/18/2014
5 Year Dividend Growth 13.97%
Next Earnings Announcement 05/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IPCA

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for IPCA

Ipca Laboratories Limited operates a pharmaceutical company, which distributes products to over 75 countries worldwide. The Group's products include finished dosage forms, drug delivery systems, bulk drugs and intermediates.

Premchand GodhaChairman/Managing Director/CEOAjit Kumar JainJoint Managing Director/CFO
Pranay GodhaExecutive DirectorPrashant GodhaExecutive Director
More Company Profile & Key Executives for IPCA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil